Breakthrough technologies and data innovation are driving cost reductions and increasing return on investment in precision medicine, fueling accelerated international market growth. With the sector poised for rapid expansion—the market is projected to reach $50.2 billion by 2028—innovators must adopt a global mindset to tackle the challenges of managing and processing data at an unprecedented scale. Addressing the shortage of trained specialists and confronting emerging ethical challenges will also be critical to unlocking the full potential of the precision medicine market and delivering for patients.
Our latest whitepaper, “Global market expansion and the future of precision medicine: The case for internationalization,” explores the significance of precision medicine, emphasizing its role in improving patient outcomes, reducing costs, and increasing ROI. It also highlights the international expansion of the market, from North America's leadership to the rapidly growing opportunities in Asia Pacific and South America.
The whitepaper discusses the global challenges of implementing precision medicine, including managing large-scale data, high clinical trial failure rates, new ethical concerns, and the shortage of specialists in genetics and big data. These challenges present significant hurdles to expanding the field but also opportunities for innovation and collaboration.
We also examine the crucial role public-private partnerships will play in expanding the market in regions with untapped potential, the importance of building robust international data policies to unlock pioneering health insights, and how breakthrough technologies are enabling precision medicine research on an extraordinary scale.
Finally, we take a close look at the strategic future of the field, focusing on how policy development and emerging technologies are fostering collaboration and driving global market growth.
Download the whitepaper to explore the latest trends and see how innovation is shaping the future of precision medicine globally.